Rezolute provides FDA review update for Phase 3 sunRIZE study
Rezolute says it has provided an update on the FDA review of its Phase 3 sunRIZE study results in congenital hyperinsulinism.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.